Klahr Saulo, Morrissey Jeremiah
Department of Internal Medicine, Washington University School of Medicine at Barnes-Jewish Hospital (North Campus), St Louis, MO 63110-1092, USA.
Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S3-7. doi: 10.1053/ajkd.2003.50074.
Risk factors for progression of kidney disease include hypertension, proteinuria, male sex, obesity, diabetes mellitus, hyperlipidemia, smoking, high-protein diets, phosphate retention, and metabolic acidosis. Angiotensin II production upregulates the expression of transforming growth factor-beta1, tumor necrosis factor-alpha, nuclear factor-kappaB, and several adhesion molecules and chemoattractants. In addition to angiotensin, other vasoactive compounds, such as thromboxane A(2), endothelin, and prostaglandins, are upregulated. Treatment with one of several growth factors may ameliorate the progression of kidney disease: insulin-like growth factor-1, hepatocyte growth factor, and bone morphogenetic protein-7.
肾病进展的危险因素包括高血压、蛋白尿、男性、肥胖、糖尿病、高脂血症、吸烟、高蛋白饮食、磷潴留和代谢性酸中毒。血管紧张素II的产生上调了转化生长因子-β1、肿瘤坏死因子-α、核因子-κB以及几种黏附分子和趋化因子的表达。除血管紧张素外,其他血管活性化合物,如血栓素A2、内皮素和前列腺素也上调。使用几种生长因子之一进行治疗可能会改善肾病的进展:胰岛素样生长因子-1、肝细胞生长因子和骨形态发生蛋白-7。